Prescription, assay and interpretation of cardiac troponins tests: Guidelines from SFBC-CNBH troponin working group;Recommandations sur la prescription, le dosage et l'interprétation des troponines cardiaques: Travail du groupe de travail mixte SFBC - CNBH « troponines »

Annales de Biologie Clinique

Volumn 63, Issue 3, 2005, Pages 245-261

  Capolaghi, B ^a,k   Charbonnier, B ^b,l   Dumontet, M ^c,k   Hennache, B ^d,k   Henninot, J ^e   Laperche, T ^f,l   Lavoinne, A ^g   Lefevre G ^h,n   Morin, C ^i,k   Pateron, D ^j,m  

^a Centre Hospitalier Regional Metz Thionville   (France)

^b SERVICE DE DERMATOLOGIE   (France)

^c CENTRE HOSPITALIER RENÉ DUBOS   (France)

^d LILLE UNIVERSITY HOSPITAL   (France)

^e Laboratoire Biolille   (France)

^f CENTRE CARDIOLOGIQUE DU NORD   (France)

^g HÔPITAL CHARLES NICOLLE   (France)

^h HÔPITAL TENON   (France)

ⁱ Laboratoire Central   (France)

^j HÔPITAL JEAN VERDIER   (France)

^k CENTRE HOSPITALIER   (France)

^l Societe Francaise de Cardiologie   (France)

^m HÔPITAL BROUSSAIS   (France)

ⁿ GERBAP (Groupe d'Evaluation et de Recherche des Biologistes de l'Ap hp Groupe Marqueurs Cardiaques)

more..

Author keywords

Acute coronary syndrome; Acute myocardial infarction; Cardiac marker; cTnI; cTnT; Guideline; Troponin

Indexed keywords

BIOLOGICAL MARKER; TROPONIN;

ACUTE DISEASE; ANIMAL; BLOOD; BLOOD ANALYSIS; HEART INFARCTION; HUMAN; PRACTICE GUIDELINE; REVIEW; STANDARD; SYNDROME; UNSTABLE ANGINA PECTORIS;

ACUTE DISEASE; ANGINA, UNSTABLE; ANIMALS; BIOLOGICAL MARKERS; BLOOD CHEMICAL ANALYSIS; HUMANS; MYOCARDIAL INFARCTION; REFERENCE STANDARDS; SYNDROME; TROPONIN;

EID: 20444501839     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (95)

1. Katus HA, Remppis A, Looser S, Hallermeier K, Scheffold T, Kubler W. Enzyme linked immuno assay of cardiac troponin T for the detection of acute myocardial infarction in patients. J Mol Cell Cardiol 1989 ; 21 : 1349-53.
2. Bodor GS, Porter S, Landt Y, Ladenson JH. Development of monoclonal antibodies for an assay of cardiac troponin-I and preliminary results in suspected cases of myocardial infarction. Clin Chem 1992 ; 38 : 2203-14.
3. Gerhardt W, Katus H, Ravkilde J, et al. S-troponin T in suspected ischemic myocardial injury compared with mass and catalytic concentrations of S-creatine kinase isoenzyme MB. Clin Chem 1991 ; 37 : 1405-11.
4. MacLellan B. La troponine I cardiaque stratus. Immunoanal Biol Spec 1995 ; 10 : 175-7.
5. Mauriat F. Marqueurs biologiques pour la détection de la souffrance cardiaque. Spectra Biol 2002 ; 21 : 28-33.
6. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined - a consensus document of the joint European society of cardiology/American college of cardiology committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000 ; 36 : 959-69.
7. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction : executive summary and recommendations. A report of the American college of cardiology/American heart association task force on practice guidelines (committee on the management of patients with unstable angina). Circulation 2000 ; 102 : 1193-209.
8. Panteghini M, Gerhardt W, Apple FS, Dati F, Ravkilde J, Wu AH. Quality specifications for cardiac troponin assays. Clin Chem Lab Med 2001 ; 39 : 175-9.
9. Apple FS, Wu AH. Myocardial infarction redefined : role of cardiac troponin testing. Clin Chem 2001 ; 47 : 377-9.
10. Panteghini M, Pagani F, Yeo KT, et al. Evaluation of imprecision for cardiac troponin assays at low-range concentrations. Clin Chem 2004 ; 50 : 327-32.
11. Vassault A, Grafmeyer D, De Graeve J, Cohen R, Beaudonnet A, Bienvenu J. Analyses de biologie médicale : spécifications et normes d'acceptabilité à l'usage de la validation de techniques. Ann Biol Clin 1999 ; 57 : 685-95.
12. Wu AH, Apple FS, Gibier WB, Jesse RL, Warshaw MM, Valdes R Jr. National academy of clinical biochemistry standards of laboratory practice : recommendations for the use of cardiac markers in coronary artery diseases. Clin Chem 1999 ; 45 : 1104-21.
13. Lefevre G, Mesguish M. Critères de choix d'un immunoanalyseur adapté au dosage de la troponine. Immunoanal Biol Spec 2001 ; 16 : 407-14.
14. Katrukha AG, Bereznikova AV, Esakova TV, et al. Troponin I is released in bloodstream of patients with acute myocardial infarction not in free form but as complex. Clin Chem 1997 ; 43 : 1379-85.
15. Panteghini M. Standardization of cardiac markers. In : Wu AHB, ed. Cardiac markers. Totowa : Humana Press, 2003 : 213-30.
16. Ferrieres G, Calzolari C, Mani JC, et al. Human cardiac troponin I : precise identification of antigenic epitopes and prediction of secondary structure. Clin Chem 1998 ; 44 : 487-93.
17. Eriksson S, Junikka M, Laitinen P, Majamaa-Voltti K, Alfthan H, Pettersson K. Negative interference in cardiac troponin I immunoassays from a frequently occurring serum and plasma component. Clin Chem 2003 ; 49 : 1095-104.
18. Panteghini M. The interfering component in cardiac troponin I immunoassays : need for further experimental evidence. Clin Chem 2004 ; 50 : 676-7.
19. Labugger R, Simpson JA, Quick M, et al. Strategy for analysis of cardiac troponins in biological samples with a combination of affinity chromatography and mass spectrometry. Clin Chem 2003 ; 49 : 873-9.
20. Liu S, Zhang MY, Song Q, Zhang X, Kadijevic L, Shi Q. Extra leader sequence affects immunoactivity of cardiac troponin I. Clin Chem 1999 ; 45 : 1300-2.
21. Stiegler H, Fischer Y, Vazquez-Jimenez JF, et al. Lower cardiac troponin T and I results in heparin-plasma than in serum. Clin Chem 2000 ; 46 : 1338-44.
22. Christenson RH, Duh SH, Apple, et al. Standardization of cardiac troponin I assays : round Robin of ten candidate reference materials. Clin Chem 2001 ; 47 : 431-7.
23. Wu AH, Feng YJ, Moore R, et al. Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I. American association for clinical chemistry subcommittee on cTnI Standardization. Clin Chem 1998 ; 44 : 1198-208.
24. Sodi R, Darn S, Stott A. Time for troponin T ? Implications from newly elucidated structure. Clin Chem 2004 ; 50 : 786-7.
25. Zabel M, Hohnloser SH, Koster W, Prinz M, Kasper W, Just H. Analysis of creatine kinase, CK-MB, myoglobin, and troponin T time-activity curves for early assessment of coronary artery reperfusion after intravenous thrombolysis. Circulation 1993 ; 87 : 1542-50.
26. Laperche T, Steg PG, Dehoux M, et al. A study of biochemical markers of reperfusion early after thrombolysis for acute myocardial infarction. The PERM study group. Prospective evaluation of reperfusion markers. Circulation 1995 ; 92 : 2079-86.
27. Tanasijevic MJ, Cannon CP, Wybenga DR, et al. Myoglobin, creatine kinase MB, and cardiac troponin-I to assess reperfusion after thrombolysis for acute myocardial infarction : results from TIMI 10A. Am Heart J 1997 ; 134 : 622-30.
28. Bertrand ME, Simoons ML, Fox KA, et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2002 ; 23 : 1809-40.
29. Antman EM, Grudzien C, Sacks DB. Evaluation of a rapid bedside assay for detection of serum cardiac troponin T. JAMA 1995 ; 273 : 1279-82.
30. Lindahl B, Venge P, Wallentin L. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. The FRISC study group. Circulation 1996 ; 93 : 1651-7.
31. Bertinchant JP, Laperche T, Polge A, et al. Signification pronostique de l'élévation précoce de la troponine I cardiaque chez les patients en angor instable. Contribution à l'identification d'un sous-groupe à risque. Arch Mal Cœur Vaiss 1997 ; 90 : 1615-22.
32. Luscher MS, Thygesen K, Ravkilde J, Heickendorff L. Applicability of cardiac troponin T and I for early risk stratification in unstable coronary artery disease. TRIM Study Group. Thrombin inhibition in myocardial ischemia. Circulation 1997 ; 96 : 2578-85.
33. Galvani M, Ottani F, Ferrini D, et al. Prognostic influence of elevated values of cardiac troponin I in patients with unstable angina. Circulation 1997 ; 95 : 2053-9.
34. Bertrand ME, Simoons ML, Fox KA, et al. Management of acute coronary syndromes : acute coronary syndromes without persistent ST segment elevation ; recommendations of the Task Force of the European society of cardiology. Eur Heart J 2000 ; 21 : 1406-32.
35. The FRISC study investigators. Invasive compared with non-invasive treatment in unstable coronary-artery disease : FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators. Lancet 1999 ; 354 : 708-15.
36. Cannon CP, Weintraub WS, Demopoulos LA, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001 ; 344 : 1879-87.
37. Hamm CW, Giannitsis E, Katus HA. Cardiac troponin elevations in patients without acute coronary syndrome. Circulation 2002 ; 106 : 2871-2.
38. Meyer T, Binder L, Hruska N, Luthe H, Buchwald AB. Cardiac troponin I elevation in acute pulmonary embolism is associated with right ventricular dysfunction. J Am Coll Cardiol 2000 ; 36 : 1632-6.
39. Giannitsis E, Muller-Bardorff M, Kurowski V, et al. Independent prognostic value of cardiac troponin T in patients with confirmed pulmonary embolism. Circulation 2000 ; 102 : 211-7.
40. Missov E, Calzolari C, Pau B. Circulating cardiac troponin I in severe congestive heart failure. Circulation 1997 ; 96 : 2953-8.
41. Setsuta K, Seino Y, Takahashi N, et al. Clinical significance of elevated levels of cardiac troponin T in patients with chronic heart failure. Am J Cardiol 1999 ; 84 : 608-11 ; A9.
42. Del Carlo CH, O'Connor CM. Cardiac troponins in congestive heart failure. Am Heart J 1999 ; 138 : 646-53.
43. Logeart D, Beyne P, Cusson C, et al. Evidence of cardiac myolysis in severe nonischemic heart failure and the potential role of increased wall strain. Am Heart J 2001 ; 141 : 247-53.
44. Dengler TJ, Zimmermann R, Braun K, et al. Elevated serum concentrations of cardiac troponin T in acute allograft rejection after human heart transplantation. J Am Coll Cardiol 1998 ; 32 : 405-12.
45. Labarrere CA, Nelson DR, Cox CJ, Pitts D, Kirlin P, Halbrook H. Cardiac-specific troponin I levels and risk of coronary artery disease and graft failure following heart transplantation. JAMA 2000 ; 284 : 457-64.
46. Ver Elst KM, Spapen HD, Nguyen DN, Garbar C, Huyghens LP, Gorus FK. Cardiac troponins I and T are biological markers of left ventricular dysfunction in septic shock. Clin Chem 2000 ; 46 : 650-7.
47. Dixit S, Castle M, Velu RP, Swisher L, Hodge C, Jaffe AS. Cardiac involvement in patients with acute neurologic disease : confirmation with cardiac troponin I. Arch Intern Med 2000 ; 160 : 3153-8.
48. Parekh N, Venkatesh B, Cross D, et al. Cardiac troponin I predicts myocardial dysfunction in aneurysmal subarachnoid hemorrhage. J Am Coll Cardiol 2000 ; 36 : 1328-35.
49. Riou B, Dreux S, Roche S, et al. Circulating cardiac troponin T in potential heart transplant donors. Circulation 1995 ; 92 : 409-14.
50. Guest TM, Ramanathan AV, Tuteur PG, Schechtman KB, Ladenson JH, Jaffe AS. Myocardial injury in critically ill patients. A frequently unrecognized complication. JAMA 1995 ; 273 : 1945-9.
51. Kollef MH, Ladenson JH, Eisenberg PR. Clinically recognized cardiac dysfunction : an independent determinant of mortality among critically ill patients. Is there a role for serial measurement of cardiac troponin I ? Chest 1997 ; 111 : 1340-7.
52. Cardinale D, Sandri MT, Martinoni A, et al. Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy. J Am Coll Cardiol 2000 ; 36 : 517-22.
53. Lipshultz SE, Rifai N, Sallan SE, et al. Predictive value of cardiac troponin T in pediatric patients at risk for myocardial injury. Circulation 1997 ; 96 : 2641-8.
54. Pateron D, Beyne P, Laperche T, et al. Elevated circulating cardiac troponin I in patients with cirrhosis. Hepatology 1999 ; 29 : 640-3.
55. Wayand D, Baum H, Schatzle G, Scharf J, Neumeier D. Cardiac troponin T and I in end-stage renal failure. Clin Chem 2000 ; 46 : 1345-50.
56. Dierkes J, Domrose U, Westphal S, et al. Cardiac troponin T predicts mortality in patients with end-stage renal disease. Circulation 2000 ; 102 : 1964-9.
57. Bertinchant JP, Polge A, Ledermann B, et al. Relation of minor cardiac troponin I elevation to late cardiac events after uncomplicated elective successful percutaneous transluminal coronary angioplasty for angina pectoris. Am J Cardiol 1999 ; 84 : 51-7.
58. Benamer H, Steg PG, Benessiano J, et al. Elevated cardiac troponin I predicts a high-risk angiographic anatomy of the culprit lesion in unstable angina. Am Heart J 1999 ; 137 : 815-20.
59. Garbarz E, Iung B, Lefevre G, et al. Frequency and prognostic value of cardiac troponin I elevation after coronary stenting. Am J Cardiol 1999 ; 84 : 515-8.
60. Fuchs S, Kornowski R, Mehran R, et al. Prognostic value of cardiac troponin-I levels following catheter-based coronary interventions. Am J Cardiol 2000 ; 85 : 1077-82.
61. Katritsis D, Hossein-Nia M, Anastasakis A, et al. Use of troponin-T concentration and kinase isoforms for quantitation of myocardial injury induced by radiofrequency catheter ablation. Eur Heart J 1997 ; 18 : 1007-13.
62. Katus HA, Schoeppenthau M, Tanzeem A, et al. Non-invasive assessment of perioperative myocardial cell damage by circulating cardiac troponin T. Br Heart J 1991 ; 65 : 259-64.
63. Ohman EM, Armstrong PW, Christenson RH, et al. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators. N Engl J Med 1996 ; 335 : 1333-41.
64. Antman EM, Tanasijevic MJ, Thompson B, et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996 ; 335 : 1342-9.
65. Holmes DR Jr, Berger PB. Troponisms, necrosettes, enzyme leaks, creatinine phosphokinase bumps, and infarctlets : what's behind this new lexicon and what does it add ? Circulation 2001 ; 104 : 627-9.
66. Stone GW, Mehran R, Dangas G, Lansky AJ, Kornowski R, Leon MB. Differential impact on survival of electrocardiographic Q-wave versus enzymatic myocardial infarction after percutaneous intervention : a device-specific analysis of 7147 patients. Circulation 2001 ; 104 : 642-7.
67. Eagle KA, Berger PB, Calkins H, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery - executive summary a report of the American college of cardiology/American heart association task force on practice guidelines (Committee to update the 1996 guidelines on perioperative cardiovascular evaluation for noncardiac surgery). Circulation 2002 ; 105 : 1257-67.
68. Braunwald E, Amman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction - summary article : a report of the American college of cardiology/American heart association task force on practice guidelines (Committee on the management of patients with unstable angina). J Am Coll Cardiol 2002 ; 40 : 1366-74.
69. Newby LK, Rutsch WR, Califf RM, et al. Time from symptom onset to treatment and outcomes after thrombolytic therapy. GUSTO-1 Investigators. J Am Coll Cardiol 1996 ; 27 : 1646-55.
70. Boersma E, Maas AC, Deckers JW, Simoons ML. Early thrombolytic treatment in acute myocardial infarction : reappraisal of the golden hour. Lancet 1996 ; 348 : 771-5.
71. Stewart S, Haste M. Prediction of right ventricular and posterior wall ST elevation by coronary care nurses : the 12-lead electrocardiograph versus the 18-lead electrocardiograph. Heart Lung 1996 ; 25 : 14-23.
72. Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction. The European myocardial infarction project group. N Engl J Med 1993 ; 329 : 383-9.
73. Viggiano M, Sicot J, Marx JS. Diagnostic et orientation des patients suspects de syndrome coronarien aigu en médecine pré hospitalière. JEUR 2000 ; 13 : 229-34.
74. Myocardial infarction redefined - a consensus document of the joint European society of cardiology/American college of cardiology committee for the redefinition of myocardial infarction. Eur Heart J 2000 ; 21 : 1502-13.
75. Hamm CW, Goldmann BU, Heeschen C, Kreymann G, Berger J, Meinertz T. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. N Engl J Med 1997 ; 337 : 1648-53.
76. Amman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T. Papuchis Gea. The TIMI risk score for unstable angina/non-ST elevation MI : A method for prognostication and therapeutic decision making. JAMA 2000 ; 284 : 835-42.
77. Roth A, Malov N, Golovner M, et al. The "SHAHAL" experience in Israel for improving diagnosis of acute coronary syndromes in the prehospital setting. Am J Cardiol 2001 ; 88 : 608-10.
78. Datta P, Foster K, Dasgupta A. Comparison of immunoreactivity of five human cardiac troponin I assays toward free and complexed forms of the antigen : implications for assay discordance. Clin Chem 1999 ; 45 : 2266-9.
79. Ishii J, Nomura M, Nakamura Y, et al. Risk stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure. Am J Cardiol 2002 ; 89 : 691-5.
80. Baillard C, Boussarsar M, Fosse JP, et al. Cardiac troponin I in patients with severe exacerbation of chronic obstructive pulmonary disease. Intensive Care Med 2003 ; 29 : 584-9.
81. Huang YS, Yang ZC, Yan BG, et al. Pathogenesis of early cardiac myocyte damage after severe burns. J Trauma 1999 ; 46 : 428-32.
82. Herman EH, Lipshultz SE, Rifai N, et al. Use of cardiac troponin T levels as an indicator of doxorubicin-induced cardiotoxicity. Cancer Res 1998 ; 58 : 195-7.
83. Orliaguet G, Ferjani M, Riou B. The heart in blunt trauma. Anesthesiology 2001 ; 95 : 544-8.
84. Adams 3rd JE, Davila-Roman VG, Bessey PQ, Blake DP, Ladenson JH, Jaffe AS. Improved detection of cardiac contusion with cardiac troponin I. Am Heart J 1996 ; 131 : 308-12.
85. Gerhardt W, Nordin G, Herbert AK, et al. Troponin T and I assays show decreased concentrations in heparin plasma compared with serum : lower recoveries in early than in late phases of myocardial injury. Clin Chem 2000 ; 46 : 817-21.
86. Katrukha A, Bereznikova A, Filatov V, Esakova T. Biochemical factors influencing measurement of cardiac troponin I in serum. Clin Chem Lab Med 1999 ; 37 : 1091-5.
87. Buechler KF, Nakamura KK. More on troponin assays and heparin. Clin Chem 2001 ; 47 : 144-7.
88. Katrukha AG, Bereznikova AV, Filatov VL, et al. Degradation of cardiac troponin I : implication for reliable immunodetection. Clin Chem 1998 ; 44 : 2433-40.
89. NF - EN - ISO 15 189. Laboratoires d'analyses de biologie médicale - Exigences particulières concernant la qualité et la compétence. Saint-Denis La Plaine : Afnor, 2003.
90. Guide de bonne exécution des analyses de biologie médicale. Deuxième édition, arrêté du 26-11-1999. Journal Officiel du 11-12 1999.
91. Internal Quality Control Testing. Principles and definitions. Document C 24 A. Villanova PA : NCCLS, 1991.
92. Chapelle JP, Dubois B, Bovy C, Aldenhoff MC, Gielen J, Rorive G. Comparison of plasma cardiac troponins T and I in chronically hemodialyzed patients in relation to cardiac status and age. Clin Chem Lab Med 2002 ; 40 : 240-5.
93. Erlacher P, Lercher A, Falkensammer J, et al. Cardiac troponin and beta-type myosin heavy chain concentrations in patients with polymyositis or dermatomyositis. Clin Chim Acta 2001 ; 306 : 27-33.
94. Apple FS, Wu AH, Jaffe AS. European society of cardiology and American college of cardiology guidelines for redefinition of myocardial infarction : how to use existing assays clinically and for clinical trials. Am Heart J 2002 ; 144 : 981-6.
95. Tate JR, Badrick T, Koumantakis G, Potter JM, Hickman PE. Reporting of cardiac troponin concentrations. Clin Chem 2002 ; 48 : 2077-80 ; author reply 80-2.